FASLG and autoimmune polyendocrinopathy: Furthermore, we noted that a human aPL monoclonal antibody obtained from a patient with APS (EY2C9) [14] exhibited complement-mediated cytotoxicity against β2GPI/HLA-DR complex-expressing cells, although neither β2GPI-expressing cells nor HLA-DR expressing cells [11].